--000000000000b4077706180c4b3b Content-Type: text/plain; charset="UTF-8" Hello Leaders The MOR slides have been rolled forward and they are ready for update. *MOR Slide updates are due Friday May 17* to allow time for the RDs to prepare for MOR. *As mentioned, this month we are making some changes:* 1) The last section of the SLIDEs will continue to be owned by the RDs, but it has been repurposed to include *Action Items and Takeaways*. The objective is for you to summarize action items and next steps. What problems are you seeing and how can they be fixed? We also want to know who will be taking those next steps and what help do you need for the corporate support teams. 2) Some sections will be shortened a little and some of the data will be summarized. I have been reaching out to the content owners to help make the changes. 3) Rate adherence will still be populated but it is being moved to an Appendix - we can go there if relevant 4) A Cash Metrics slides will be introduced this month by the OTC team - more to come Here is the link of takeaways for the current MOR. Please review and add comments. FP&A will continue to follow up on these items. https://docs.google.com/spreadsheets/d/1YFEO1naknE5_2XcxQ8Mm9Z_7KewObDMOqhsQhQ09QZk/edit?usp=sharing Please let me know if you have any questions. Thanks, *Diego Castaneda* Head of FP&A --000000000000b4077706180c4b3b Content-Type: text/html; charset="UTF-8" Content-Transfer-Encoding: quoted-printable Hello Leaders The MOR slides have been rolled forward = and they are ready for update.=C2=A0 MOR Slide updates are due Friday May 17 to allow time for= the RDs to prepare for MOR.=C2=A0 As mentioned= , this=C2=A0month we are making some changes: 1) The last sec= tion of the SLIDEs will continue to be owned by the RDs, but it has been re= purposed to include Action Items and Takeaways . The objective is for= =C2=A0you to summarize action items and next steps. What problems are you s= eeing and how can they be fixed? We also want to know who will be taking th= ose next steps and what help do=C2=A0you need for the corporate support tea= ms. 2) Some sections will be shortened a little and some of the d= ata will be summarized. I have been reaching out to the content=C2=A0owners= to help make the changes. 3) Rate adherence=C2=A0will still be p= opulated but it is being moved=C2=A0to an Appendix - we can go there if rel= evant 4) A Cash Metrics slides will be introduced=C2=A0this month= by the OTC team - more to come=C2=A0 Here is the = link of takeaways for the current MOR. Please review and add comments. FP&a= mp;A will continue to follow up on these items. https://docs.google.com/spreadsheets/d/1YFEO1naknE5_2XcxQ8Mm9Z_7KewObDMO= qhsQhQ09QZk/edit?usp=3Dsharing Please let me know if you have any question= s. Thanks, Diego Castaneda Head of FP&A = --000000000000b4077706180c4b3b--